2 not yet recruiting, 1 completed, 1 no longer available, 1 unknown. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 2, Completed 1, Unknown 1 |
Follow SurVaxM: new trials by email Literature Review of SurVaxM trials Research Report on SurVaxM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas Biospecimen Collection, Computed Tomography, Incomplete Freund''s Adjuvant - Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm | Phase 2 | Not yet recruiting | Roswell Park Cancer Institute | 60 | 2026-12-15 | 2026-10-20 |
| Testing the SurVaxM Vaccine for Lung Cancer Prevention Biospecimen Collection, Montanide ISA 51 VG, Questionnaire Administration - Lung Carcinoma | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 80 | 2026-10-01 | 2026-08-26 |
| SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) SurVaxM - Newly Diagnosed Glioblastoma | Phase 2 | Unknown | MimiVax, LLC | 247 | 2021-11-18 | 2024-02-26 |
| Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence Pembrolizumab, SurVaxM, Sargramostim - Recurrent Glioblastoma | Phase 2 | Completed | David Peereboom | 41 | 2020-03-19 | 2024-08-28 |
| SurVaxM Expanded Access Protocol SurVaxM - Glioblastoma | No longer available | Roswell Park Cancer Institute | 2025-09-16 |
Glioblastoma (2) · Adenoma, Islet Cell (1) · Lung Neoplasms (1)
Roswell Park Cancer Institute (2) · David Peereboom (1) · MimiVax, LLC (1) · National Cancer Institute (NCI) (1)
United States (4)
Ajay Abad, MD (1) · David Peereboom, MD (1) · Jasmeet Kaur, MD (1) · Manmeet S Ahluwalia, MD, MBA (1) · Michael Ciesielski, PhD (1) · Robert Fenstermaker, MD (1) · Saikrishna S Yendamuri (1)
PMID 10318881, PMID 10623795, PMID 10725753, PMID 10766164, PMID 11221872, PMID 12070671, PMID 12135582, PMID 15758009, PMID 16582593, PMID 16731740, PMID 16918305, PMID 18056471, PMID 20231676, PMID 20422411, PMID 27576783, PMID 29540489, PMID 29921698, PMID 9422522, PMID 9858522
P30CA060553 (1), UG1CA242643 (1)